Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

3 studies match

clinicaltrialsPublishedShowing 1–3 of 3 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03229200	Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.	active not recruiting	Phase 4	297	Pharmacyclics Switzerland GmbHINDUSTRY	17	Oct 30, 2025	clinicaltrials
NCT04078152	Durvalumab Long-Term Safety and Efficacy Study(WAVE)	completed	Phase 4	163	AstraZenecaINDUSTRY	31	Dec 20, 2024	clinicaltrials